Stocks/ANGX

ANGX three-lens brief

Evidence-based stock research on ANGX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$2.05$5.38$18.90

Performance

1W
+19.8%
1M
+40.5%
3M
6M
YTD
1Y
3Y
5Y
ANGX · Nightly brief
Inspect

Price up 9.13% in the last session — a material single-day move. · RSI at 71 — technically overbought.

  • Price up 9.13% in the last session — a material single-day move.
  • 50-day MA above 200-day MA (golden-cross regime); price above both.
  • RSI at 71 — technically overbought.
  • Outperforming SPY by 33.4pp over 30 days.
  • Currently unprofitable on a trailing basis — no P/E multiple available.

ANGX closed at $5.38 (+9.13%) as of 2026-09-11. Market cap: $1.00B. Price is above the 50-day MA and above the 200-day MA. Positives: price up 9.13% in the last session — a material single-day move.; 50-day MA above 200-day MA (golden-cross regime); price above both.. Concerns: rSI at 71 — technically overbought.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $111.71M, net income -$23.79M, free cash flow $8.14M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on ANGX, not one.

A single reasoning model has blind spots it doesn’t know about. We examine ANGXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/ANGX"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath ANGX brief"></iframe>